P516-0607 Screening compound: N-[3-(2-ethylpiperidin-1-yl)propyl]-7-methyl-4-oxo-4H,5H-[1,2,3]triazolo[1,5-a]quinoxaline-3-carboxamide

P516-0607 Screening compound: N-[3-(2-ethylpiperidin-1-yl)propyl]-7-methyl-4-oxo-4H,5H-[1,2,3]triazolo[1,5-a]quinoxaline-3-carboxamide
P516-0607 Screening compound: N-[3-(2-ethylpiperidin-1-yl)propyl]-7-methyl-4-oxo-4H,5H-[1,2,3]triazolo[1,5-a]quinoxaline-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P516-0607
N-[3-(2-ethylpiperidin-1-yl)propyl]-7-methyl-4-oxo-4H,5H-[1,2,3]triazolo[1,5-a]quinoxaline-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P516-0607

Molecular Formula

C21H28N6O2 (C21 H28 N6 O2)

Compound Name

N-[3-(2-ethylpiperidin-1-yl)propyl]-7-methyl-4-oxo-4H,5H-[1,2,3]triazolo[1,5-a]quinoxaline-3-carboxamide

IUPAC name

N-[3-(2-ethylpiperidin-1-yl)propyl]-7-methyl-4-oxo-4H5H-[123]triazolo[15-a]quinoxaline-3-carboxamide

SMILES

CCC1N(CCCNC(c2c(C(Nc3c-4ccc(C)c3)=O)n4nn2)=O)CCCC1

InChI

InChI=1S/C21H28N6O2/c1-3-15-7-4-5-11-26(15)12-6-10-22-20(28)18-19-21(29)23-16-13-14(2)8-9-17(16)27(19)25-24-18/h8-9,13,15H,3-7,10-12H2,1-2H3,(H,22,28)(H,23,29)/t15-/m0/s1

InChI Key

OBKVWLXYFGOXMQ-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD27603492

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

396.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.005

Distribution Coefficient, logD

-0.862

Water Solubility, LogSw

-2.58

Polar Surface Area

78.307

Acid Dissociation Constant (pKa)

8.75

Base Dissociation Constant (pKb)

10.27

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.40

P516-0607 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P516-0607 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P516-0607?
Check Price and Availability of P516-0607, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P516-0607 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P516-0607
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P516-0607
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P516-0607 available by request